Gr. Sarantis S.A
Gr. Sarantis S.A., together with its subsidiaries, produces and trades in cosmetics, household products, and pharmaceutical items in Greece, Portugal, Poland, Romania, Bulgaria, Serbia, Bosnia-Herzegovina, North Macedonia, Slovenia, Czech-Slovakia, Hungary, and Ukraine. It operates through Beauty/Skin/Sun Care, Personal Care, Home Care Solutions, Private Label, Strategic Partnerships, and Other S… Read more
Gr. Sarantis S.A (SRTSF) - Net Assets
Latest net assets as of June 2025: $378.51 Million USD
Based on the latest financial reports, Gr. Sarantis S.A (SRTSF) has net assets worth $378.51 Million USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($621.08 Million) and total liabilities ($242.57 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $378.51 Million |
| % of Total Assets | 60.94% |
| Annual Growth Rate | 9.86% |
| 5-Year Change | 37.57% |
| 10-Year Change | 123.95% |
| Growth Volatility | 6.6 |
Gr. Sarantis S.A - Net Assets Trend (2005–2024)
This chart illustrates how Gr. Sarantis S.A's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Gr. Sarantis S.A (2005–2024)
The table below shows the annual net assets of Gr. Sarantis S.A from 2005 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $374.91 Million | +6.01% |
| 2023-12-31 | $353.64 Million | +6.92% |
| 2022-12-31 | $330.74 Million | +10.25% |
| 2021-12-31 | $299.99 Million | +10.08% |
| 2020-12-31 | $272.52 Million | +7.45% |
| 2019-12-31 | $253.64 Million | +12.91% |
| 2018-12-31 | $224.63 Million | +11.51% |
| 2017-12-31 | $201.44 Million | +9.46% |
| 2016-12-31 | $184.03 Million | +9.93% |
| 2015-12-31 | $167.41 Million | +4.87% |
| 2014-12-31 | $159.64 Million | +3.36% |
| 2013-12-31 | $154.44 Million | +8.30% |
| 2012-12-31 | $142.60 Million | +12.71% |
| 2011-12-31 | $126.53 Million | +1.86% |
| 2010-12-31 | $124.22 Million | +7.47% |
| 2009-12-31 | $115.59 Million | +10.31% |
| 2008-12-31 | $104.78 Million | +3.30% |
| 2007-12-31 | $101.43 Million | +26.15% |
| 2006-12-31 | $80.40 Million | +28.08% |
| 2005-12-31 | $62.78 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Gr. Sarantis S.A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 29928633500.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $265.07 Million | 70.76% |
| Common Stock | $52.14 Million | 13.92% |
| Other Components | $57.41 Million | 15.33% |
| Total Equity | $374.63 Million | 100.00% |
Gr. Sarantis S.A Competitors by Market Cap
The table below lists competitors of Gr. Sarantis S.A ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Surya Esa Perkasa Tbk
JK:ESSA
|
$432.22 Million |
|
Chinhung International Inc. Pfd. Series 2
KO:002787
|
$432.23 Million |
|
SCOR PK
PINK:SCRYY
|
$432.24 Million |
|
Bichamp Cutting Technology Hunan Co Ltd
SHE:002843
|
$432.29 Million |
|
Sunflower Pharmaceuticals Group Co Ltd
SHE:002737
|
$432.08 Million |
|
NORTHRIM BA. DL-01
F:NRI
|
$432.03 Million |
|
Sichuan Golden Summit Group Joint Stock Co Ltd
SHG:600678
|
$431.97 Million |
|
Neurones
PA:NRO
|
$431.86 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Gr. Sarantis S.A's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 353,641,101 to 374,627,113, a change of 20,986,012 (5.9%).
- Net income of 46,020,473 contributed positively to equity growth.
- Dividend payments of 14,666,113 reduced retained earnings.
- Share repurchases of 15,836,366 reduced equity.
- Other comprehensive income decreased equity by 20,282,495.
- Other factors increased equity by 25,750,513.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $46.02 Million | +12.28% |
| Dividends Paid | $14.67 Million | -3.91% |
| Share Repurchases | $15.84 Million | -4.23% |
| Other Comprehensive Income | $-20.28 Million | -5.41% |
| Other Changes | $25.75 Million | +6.87% |
| Total Change | $- | 5.93% |
Book Value vs Market Value Analysis
This analysis compares Gr. Sarantis S.A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.51x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 18.11x to 2.51x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-12-31 | $0.80 | $14.46 | x |
| 2006-12-31 | $1.01 | $14.46 | x |
| 2007-12-31 | $1.32 | $14.46 | x |
| 2008-12-31 | $1.37 | $14.46 | x |
| 2009-12-31 | $1.51 | $14.46 | x |
| 2010-12-31 | $1.62 | $14.46 | x |
| 2011-12-31 | $1.65 | $14.46 | x |
| 2012-12-31 | $2.05 | $14.46 | x |
| 2013-12-31 | $2.22 | $14.46 | x |
| 2014-12-31 | $2.30 | $14.46 | x |
| 2015-12-31 | $2.39 | $14.46 | x |
| 2016-12-31 | $2.63 | $14.46 | x |
| 2017-12-31 | $2.92 | $14.46 | x |
| 2018-12-31 | $3.27 | $14.46 | x |
| 2019-12-31 | $3.74 | $14.46 | x |
| 2020-12-31 | $4.02 | $14.46 | x |
| 2021-12-31 | $4.45 | $14.46 | x |
| 2022-12-31 | $4.91 | $14.46 | x |
| 2023-12-31 | $5.31 | $14.46 | x |
| 2024-12-31 | $5.77 | $14.46 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Gr. Sarantis S.A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 12.28%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 7.67%
- • Asset Turnover: 1.00x
- • Equity Multiplier: 1.60x
- Recent ROE (12.28%) is below the historical average (15.13%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2005 | 31.73% | 9.26% | 0.96x | 3.57x | $13.24 Million |
| 2006 | 29.28% | 10.16% | 0.96x | 3.00x | $14.93 Million |
| 2007 | 30.40% | 12.78% | 0.99x | 2.41x | $20.72 Million |
| 2008 | 24.23% | 9.79% | 1.13x | 2.19x | $14.91 Million |
| 2009 | 14.19% | 7.43% | 0.99x | 1.93x | $4.84 Million |
| 2010 | 9.52% | 5.29% | 0.92x | 1.95x | $-600.60K |
| 2011 | 7.70% | 4.40% | 0.92x | 1.90x | $-2.91 Million |
| 2012 | 8.52% | 5.15% | 0.96x | 1.73x | $-2.11 Million |
| 2013 | 5.38% | 3.52% | 1.00x | 1.54x | $-7.13 Million |
| 2014 | 10.74% | 6.90% | 1.08x | 1.45x | $1.18 Million |
| 2015 | 11.14% | 6.65% | 1.05x | 1.60x | $1.89 Million |
| 2016 | 10.54% | 5.86% | 1.16x | 1.55x | $994.86K |
| 2017 | 14.32% | 8.34% | 1.12x | 1.53x | $8.63 Million |
| 2018 | 14.66% | 9.46% | 0.97x | 1.60x | $10.35 Million |
| 2019 | 15.13% | 10.27% | 0.88x | 1.68x | $12.88 Million |
| 2020 | 14.34% | 9.84% | 0.90x | 1.61x | $11.71 Million |
| 2021 | 13.52% | 9.87% | 0.88x | 1.55x | $10.50 Million |
| 2022 | 13.82% | 10.17% | 0.89x | 1.52x | $12.54 Million |
| 2023 | 11.12% | 8.15% | 0.87x | 1.57x | $3.94 Million |
| 2024 | 12.28% | 7.67% | 1.00x | 1.60x | $8.56 Million |
Industry Comparison
This section compares Gr. Sarantis S.A's net assets metrics with peer companies in the Household & Personal Products industry.
Industry Context
- Industry: Household & Personal Products
- Average net assets among peers: $1,833,853,398
- Average return on equity (ROE) among peers: 27.58%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Gr. Sarantis S.A (SRTSF) | $378.51 Million | 31.73% | 0.64x | $432.15 Million |
| Acme United Corporation (ACU) | $19.90 Million | 2.51% | 0.55x | $132.86 Million |
| Beiersdorf Aktiengesellschaft (BDRFF) | $3.02 Billion | 8.59% | 0.75x | $11.93 Billion |
| Science to Consumers Inc (BEUT) | $-3.05K | 0.00% | 0.00x | $1.09K |
| Société BIC SA (BICEY) | $1.70 Billion | 16.88% | 0.41x | $566.61 Million |
| Blue Moon Group Holdings Limited (BLUMY) | $12.35 Billion | 8.22% | 0.18x | $1.01 Billion |
| Bemax Inc (BMXC) | $-244.86K | 0.00% | 0.00x | $3.63K |
| Bruush Oral Care Inc. (BRSHF) | $-216.93K | 0.00% | 0.00x | $335.48 |
| Park Ha Biological Technology Co., Ltd. (BYAH) | $-578.18K | 0.00% | 0.00x | $11.97 Million |
| Church & Dwight Company Inc (CHD) | $284.43 Million | 16.52% | 2.34x | $22.97 Billion |
| Colgate-Palmolive Company (CL) | $971.00 Million | 223.07% | 14.49x | $67.85 Billion |